A Case of Hemophagocytic Lymphohistiocytosis Induced by Regorafenib
Archives of Clinical and Medical Case Reports , Volume 5, pp 96-100; doi:10.26502/acmcr.96550332
Abstract: Hemophagocytic lymphohistiocytosis (HLH) is a rare and severe condition of immune dysregulation characterized by severe organ damage induced by a hyperinflammatory response and uncontrolled T-cell and macrophage activation. Secondary HLH, also known as macrophage activation syndrome, commonly presents in adulthood and characterized by acquired immune dysfunction in response to infections, malignancies, or autoinflammatory/autoimmune disorders. Secondary HLH induced by regorafenib has not been yet described. Here we report a case of HLH induced by regorafenib, confirmed by clinical, laboratory and histopathological findings, with typical results on bone marrow aspiration.
Keywords: Macrophage / bone marrow / HLH / adulthood / dysregulation / Uncontrolled / hemophagocytic / Lymphohistiocytosis / Induced by Regorafenib
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Archives of Clinical and Medical Case Reports" .